
Dukinase 75000IU Injection
Marketer
Taj Pharma India Ltd
Salt Composition
Urokinase (75000IU)
Overview Dukinase 75000IU Injection
Administered under medical supervision, the thrombolytic agent Dukinase 75000IU Injection dissolves dangerous blood clots obstructing blood vessels. Primarily employed in post-heart attack care, it also finds application in treating pulmonary embolism and stroke. Dosage and treatment duration are determined individually by your physician, who will closely monitor your progress until stabilization. Potential side effects include nausea, vomiting, injection site hemorrhage, allergic responses, and hypotension. Increased bleeding risk is also possible. Your doctor will discuss the risks and benefits prior to treatment. Concurrently prescribed medications should be continued. Caution is advised for individuals with bleeding disorders, hepatic or renal impairment, or those who are pregnant or nursing. Complete disclosure of all current medications and pre-existing conditions is crucial.
Uses of Dukinase 75000IU Injection
Myocardial infarction/Pulmonary thromboembolism
Major Benefits of Dukinase 75000IU Injection:
Administering this medication requires a healthcare professional; your doctor or nurse will provide it to you. Self-medication is strongly discouraged.
Common Side effects of Dukinase 75000IU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Dukinase 75000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Dukinase 75000IU Injection works:
Dukinase 75000IU Injection facilitates the breakdown of dangerous blood clots within the vascular system. This action re-establishes blood circulation to compromised tissues, mitigating tissue necrosis and enhancing patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Dukinase 75000IU Injection is undetermined. Seek medical advice.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Dukinase 75000IU Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Dukinase 75000IU Injection during lactation is likely safe. Available human data indicates minimal risk to the infant.
DrivingNOT RELEVANT
Dukinase 75000IU Injection is exclusively administered in a hospital setting.
KidneySAFE IF PRESCRIBED
The use of Dukinase 75000IU Injection in patients with kidney disease is likely safe, with limited evidence suggesting dose modification isn't necessary. However, it's advisable to seek medical advice. Dukinase 75000IU Injection is contraindicated in patients with severe kidney impairment.
LiverCAUTION
For individuals with hepatic impairment, administering Dukinase 75000IU Injection requires careful consideration. Dosage modification of Dukinase 75000IU Injection might be necessary. Physician consultation is advised.
What if you forget to take Dukinase 75000IU Injection :
Should you forget a Dukinase 75000IU Injection, seek your physician's advice.
Facts to Know About Dukinase 75000IU Injection
| Label | Value |
|---|---|
| Chemical Classification | Amino acid and peptide analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Early Thrombolytic Agents |
